What are the side effects of Mirapex (pramipexole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Mirapex (Pramipexole)

Pramipexole (Mirapex) is associated with significant side effects including somnolence, dizziness, impulse control disorders, and augmentation with long-term use, which is why the American Academy of Sleep Medicine suggests against its standard use for conditions like Restless Legs Syndrome despite its effectiveness. 1, 2

Common Side Effects

  • Nervous system effects are the most common side effects, including:

    • Somnolence/sleepiness (may affect daily activities) 3
    • Dizziness (reported in clinical trials as a leading cause of discontinuation) 3
    • Headache 3
  • Gastrointestinal effects:

    • Nausea (reported in 2.1% of patients as a cause for discontinuation) 3
    • Constipation (frequency increases with higher doses) 3
    • Dry mouth 3
  • Psychiatric effects:

    • Hallucinations (3.1% discontinuation rate, with higher risk in elderly patients) 3
    • Confusion (1.0% discontinuation rate) 3
    • Dream abnormalities 3

Serious Side Effects

  • Impulse control disorders:

    • Pathological gambling 2
    • Hypersexuality 2
    • Compulsive shopping 2
    • These behaviors typically resolve when the medication is reduced or discontinued 3
  • Cardiovascular effects:

    • Orthostatic hypotension (particularly concerning in older adults) 1, 4
    • Syncope 3
  • Movement disorders:

    • Dyskinesia (especially when used with levodopa in Parkinson's disease) 3
    • Extrapyramidal syndrome 3
    • Dystonia 3

Long-Term Complications

  • Augmentation:

    • Characterized by worsening of symptoms with long-term use 1, 2
    • Earlier onset of symptoms during the day 1
    • Increased intensity of symptoms 1
    • Spread to other body parts (e.g., from calves to thighs) 1
    • This is a major concern with dopaminergic medications for RLS 1
  • Tolerance:

    • Diminished effectiveness over time requiring dose adjustments 1

Overdose Symptoms

  • Visual hallucinations 5
  • Agitation 5
  • Myoclonus 5
  • Urinary retention 5
  • Ataxia 5

Special Population Considerations

  • Elderly patients:

    • Higher risk of hallucinations 3
    • Increased sensitivity to orthostatic hypotension 4
    • Greater risk of sedation 4
  • Patients with cognitive impairment:

    • May exacerbate symptoms in patients with Dementia with Lewy Bodies 2

Drug Interactions

  • Dopamine antagonists (neuroleptics, metoclopramide) may reduce effectiveness 4
  • Increased risk of CNS depression when combined with opioids 4
  • Requires cautious use with multiple medications due to potential interactions 4

Practical Considerations

  • Side effects are often dose-dependent, with higher frequencies at doses above 3 mg/day 3
  • Starting at the lowest effective dose (0.125 mg) can minimize adverse effects 4
  • Most side effects are mild to moderate in intensity but may lead to discontinuation 3
  • The risk-benefit profile should be carefully evaluated, particularly for long-term use 1, 2

Monitoring Recommendations

  • Regular assessment for emergence of impulse control disorders 2
  • Monitoring for signs of augmentation in RLS patients 1
  • Evaluation of orthostatic blood pressure changes, particularly in elderly patients 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pramipexole for Sleep Disorders and Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Drug-Drug Interactions with Pramipexole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pramipexole Overdose Associated with Visual Hallucinations, Agitation and Myoclonus.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.